p44/42 MAP Kinase Assay Kit (Nonradioactive) #9800
Inquiry Info. # 9800
Please see our recommended alternatives.
Product Information
Protocol
Product Description
Specificity / Sensitivity
Species Reactivity:
Background
- Roux, P.P. and Blenis, J. (2004) Microbiol Mol Biol Rev 68, 320-44.
- Baccarini, M. (2005) FEBS Lett 579, 3271-7.
- Meloche, S. and Pouysségur, J. (2007) Oncogene 26, 3227-39.
- Roberts, P.J. and Der, C.J. (2007) Oncogene 26, 3291-310.
- Rubinfeld, H. and Seger, R. (2005) Mol Biotechnol 31, 151-74.
- Murphy, L.O. and Blenis, J. (2006) Trends Biochem Sci 31, 268-75.
- Dalby, K.N. et al. (1998) J Biol Chem 273, 1496-505.
- Marais, R. et al. (1993) Cell 73, 381-93.
- Kortenjann, M. et al. (1994) Mol Cell Biol 14, 4815-24.
- Owens, D.M. and Keyse, S.M. (2007) Oncogene 26, 3203-13.
Product Citations: 13
- Phuchareon, J. et al. (2015) Proc Natl Acad Sci U S A 112, E3855-63.
- Russell, K.S. et al. (2000) Proc Natl Acad Sci U S A 97, 5930-5.
- Tan, J. et al. (2000) J Neurosci 20, 7587-94.
- Jost, M. et al. (2001) J Biol Chem 276, 6320-6.
- Skapenko, A. et al. (2001) J Immunol 166, 4283-92.
- Gui, Y. and Zheng, X.L. (2003) J Biol Chem 278, 53017-25.
- Hsu, H.Y. et al. (2004) J Immunol 173, 5989-99.
- Wong, C.H. et al. (2005) Endocrinology 146, 1192-204.
- He, Z. et al. (2005) J Biol Chem 280, 2446-54.
- Schlezinger, J.J. et al. (2006) Toxicol Sci 92, 433-44.
- Jia, W. et al. (2006) Mol Cancer Res 4, 549-62.
- Zampieri, C.A. et al. (2007) J Virol 81, 1230-40.
- Ha, U. et al. (2007) J Immunol 178, 1736-47.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.